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Abstract:  Hypoxia  is  a  common  environmental  stress  factor  and  is  associated  with 
fibrogenesis.  Matrix  metalloproteinase-2  (MMP-2),  produced  by  hepatic  stellate  cells 
(HSCs), plays an important role in liver fibrogenesis. However, inconsistent results have 
been reported on the impact of hypoxia on MMP-2 expression and activity in HSCs. We 
speculated that cell–cell interaction is involved in the regulation of MMP-2 expression and 
activity  at  low  oxygen  level  in  vivo.  Therefore,  in  this  report  we  investigated  the 
mechanism  by  which  hypoxic  hepatocytes  regulates  MMP-2  expression  in  HSCs.  Our 
results showed that the conditioned medium from hypoxia-treated rat hepatocytes strongly 
induced  the  expression  of  MMP-2  mRNA  and  protein  in  rat  HSC-T6  cells.  Reduced 
glutathione  neutralized  ROS  released  from  hypoxic  hepatocytes,  leading  to  reduced  
MMP-2  expression  in  HSC-T6  cells.  In  addition,  phospho-IκB-α  protein  level  was 
increased in HSC-T6 cells treated with hypoxia conditioned medium, and NF-κB signaling 
inhibitor inhibited MMP-2 expression in HSC-T6 cells. Taken together, our data suggest 
that  ROS  is  an  important  factor  released  by  hypoxic  hepatocytes  to  regulate  MMP-2 
expression in HSCs, and NF-κB signaling is crucially involved in ROS-induced MMP-2 
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expression  in  HSCs.  Our  findings  suggest  that  strategies  aimed  at  antagonizing  the 
generation of ROS in hypoxic hepatocytes and inhibiting NF-κB signaling in HSCs may 
represent novel therapeutic options for liver fibrosis. 
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1. Introduction 
It is estimated that over 100 million people suffer from liver fibrosis in the world. As the main 
complication of chronic liver damage, liver fibrosis is a wound healing process characterized by the 
accumulation of extracellular matrix (ECM) proteins in the liver. Although liver fibrosis is caused by a 
variety of etiologic agents, including chronic viral hepatitis, alcohol toxicity, autoimmune disease, and 
hereditary  metabolic  disorders,  it  is  now  generally  accepted  that  a  central  pathologic  mechanism 
underlying liver fibrosis is the generation and proliferation of smooth muscle α-actin (α-SMA)-positive 
myofibroblasts of periportal and perisinusoidal origin that arise as a consequence of the activation of 
hepatic  stellate  cells  (HSCs)  [1–3,4].  HSCs  play  a  critical  role  in  the  excessive  production  and 
secretion of ECM, resulting in the generation of fibrous tissue and scar formation [5]. The activation of 
HSCs is considered to be the key factor responsible for liver fibrosis [1]. In addition to cytokines and 
other soluble factors released by Kupffer cells, inflammatory cells and damaged hepatocytes, changes 
of ECM composition have been suggested to be implicated in the activation of HSCs [6].  
Enzymes known to degrade type IV collagen include matrix metalloproteinase-2 (MMP-2) and 
matrix  metalloproteinase-9  (MMP-9),  both  of  which  are  members  of  zinc-dependent  matrix 
metalloproteinase  family.  MMP-2  is  involved  in  ECM  remodeling  during  tissue  and  organ 
development, wound repair, tumor invasion and metastasis. It has been shown that activated HSCs 
proliferate quickly and produce a large amount of ECM and MMP-2 [7,8]. Therefore, MMP-2 and 
HSCs activation are interdependent. During the progression of liver fibrosis, deposition of type Ⅳ 
collagen increases significantly, which might be due to the inability of MMP-2 to degrade type Ⅳ 
collagen. If the expression and activity of MMP-2 were interfered at different stages, the progression 
of  liver  fibrosis  may  be  changed.  Thus,  further  characterization  of  HSCs  is  crucial  for  the 
understanding of the pathogenesis of hepatic fibrosis.  
Many factors have been shown to affect MMP-2 expression and activity in HSCs, such as reactive 
oxygen species (ROS) generated during oxidative stress, transforming growth factor β1 (TGF-β1), 
p53,  AP-1,  membrane-type  matrix  metalloproteinase  (MT1-MMP),  tissue  inhibitor  of  matrix 
metalloproteinase-2 (TIMP-2), plasmin, thrombin, typeⅠcollagen, Zn
2+, reversion-inducing-cysteine-rich 
protein  with  Kazal  motifs  (RECK),  and  the  interaction  between  hepatocytes  and  hepatic  stellate  
cells [9–11]. Oxygen is necessary for cellular metabolic process and acts as a modulator of gene 
expression [12]. One of the most prominently pathological significance of hypoxic mammals is an 
increase in ECM synthesis. The steady-state concentration of the collagens depends on both the rate of 
their synthesis and their degradation. Hypoxia is involved in the pathogenic process of liver fibrosis 
and may activate HSCs [13–15]. In addition, our previous studies have shown that hypoxia stimulated 
MMP-2 synthesis in HSCs in vitro, and the expression of hypoxia inducible factor-1α was increased in Int. J. Mol. Sci. 2011, 12                       
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hepatocytes  in  the  rat  liver  fibrosis  tissues  [16–18].  However,  it  is  unknown  whether  and  how 
hepatocytes modulate MMP-2 expression in HSCs under hypoxic conditions. Therefore, in this study 
we investigated the mechanism by which hypoxic hepatocytes regulates MMP-2 expression in HSCs. 
Our results suggest that ROS is an important factor released by hypoxic hepatocyte to regulate MMP-2 
expression in HSCs and NF-κB signaling is crucially involved in these processes. 
2. Materials and Methods 
2.1. Cell Culture and Preparation of Conditioned Media 
Rat  hepatocyte BRL-3A cells  and  hepatic stellate  cell HSC-T6 cells were  obtained  from Type 
Culture  Collection  of  Chinese  Academy  of  Sciences  and  cultured  in  Dulbecco’s  modified  Eagle 
medium  (DMEM,  Invitrogen,  USA)  containing  10%  fetal  calf  serum  (FBS,  Gibco,  USA)  and  
100 units/mL penicillin/streptomycin at 37 ° C in a humidified atmosphere with 5% CO2. Cells were 
plated in 6-well plates at a density of 2 ×  10
5 cells/well. At 80% confluence, BRL-3A cells were 
treated  with  hypoxia.  The  cells  were  replaced  with  serum-free  DMEM  and  then  incubated  in  the 
chambers flushed with air mixture containing 1% O2, 5% CO2 and 94% N2 for 30 min. The ultimate 
oxygen tension was 5%. The chambers were sealed and placed at 37 ° C and incubated for 12 h. 
Controls included parallel cultures in which cells were exposed to ambient air (e.g., normaxia/21% 
oxygen tension). The supernatant was collected from the cultured cells at 12 h and passed through a 
0.22 μm filter. The filtrate was defined as hypoxia conditioned medium and normoxia conditioned 
medium. The conditioned medium was used immediately for following experiments. 
To induce HSC-T6 cell differentiation and MMP-2 expression by hypoxia conditioned medium, 
HSC-T6 cells were grown to 80% confluence and then washed twice with PBS. Then HSC-T6 cells 
were cultured in hypoxia conditioned medium and collected after 6 h, 12 h and 24 h, respectively. As 
controls, HSC-T6 cells were cultured in DMEM medium or normoxia conditioned medium. All the 
cells were cultured in a humidified atmosphere of 5% CO2 and 95% air at 37 ° C.  
2.2. Real-Time RT-PCR 
Total RNA was extracted from HSC-T6 cells with Trizol reagent (Invitrogen, USA) following the 
manufacturer’s instructions. Total RNA (1 μg) was used for cDNA synthesis using PrimeScript RT reagent 
kit  (TaKaRa,  Dalian,  China).  Aliquot  of  diluted  first-strand  cDNA  was  amplified  with  a  Real-Time  
PCR  Detection  System  (ABI7300,  USA)  using  SYBR  PrimeScript  RT-PCR  Kit  according  to  the 
manufacturer’s instructions. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an 
internal control. The following primers were used: MMP-2, 5-AGGGCACCTCCTACAACAGC-3 and 
5-CAGTGGACATAGCGGTCTCG-3 (126 bp) [19]; GAPDH, 5-GAAGGGCTCATGACCACAGT-3 
and 5-GGATGCAGGGATGATGTTCT-3 (117 bp) [20]. RT-PCR was performed three times in triplicate. 
The relative mRNA level of MMP-2 was compared to that of GAPDH and was calculated by the 2
−ΔΔCt 
method. Each Ct value used for these calculations was the mean of the triplicate for each reaction.  Int. J. Mol. Sci. 2011, 12                       
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2.3. Western Blot  
HSC-T6  cells  were  lysed  with  RIPA  lysis  buffer  (Beyotime,  China).  After  centrifugation,  the 
lysates were determined by the Bradford assay (Beyotime, China) for protein concentration. Total 
protein  for  each  sample  (50  μg)  was  fractionated  on  10%  SDS-PAGE  gel  and  transferred  to 
polyvinylidene difluoride (PVDF) membrane. The membrane was blocked with 5% skimmed milk at 
room temperature for 1 h and incubated with the rabbit polyclonal anti-MMP-2 antibody (Bioworld, 
China, 1:500 dilution), phospho-IκB-α antibody (Bioworld, China, 1:500 dilution), IκB-α antibody 
(Bioworld,  China,  1:500  dilution),  or  mouse  monoclonal  anti-β-actin  antibody  (Santa  Cruz,  USA, 
1:1000 dilution) at 4 ° C overnight. After washing, the membrane was incubated with horseradish 
peroxidase-conjugated anti-goat or anti-mouse antibody (Santa Cruz, USA, 1:10,000 dilution) at room 
temperature for 1 h. After washing, the bound antibody was visualized with Super ECL Detection 
Reagent (Applygen, China). 
2.4. Gelatin Zymography for MMP-2  
MMP-2 activity was determined by gelatin zymography. Supernatants were collected from HSC-T6 
cells and centrifuged. Protein content of the supernatants was determined by the Bradford assay. Total 
protein for each sample (15 μg) was fractionated on 10% SDS-PAGE gel containing 0.1% gelatin 
under non-reducing conditions. Gelatin zymography was performed using a MMP Zymography assay 
kit (Applygen Technologies Inc.) according to the manufacturer’s instructions. Gelatinolytic bands 
were observed as clear zones against the blue background and the intensity of the bands was estimated 
using the ScnImage Software. 
2.5. Quantitative Assay for Reactive Oxygen Species  
BRL-3A cells were cultured and treated with hypoxia as previously described in 96-well plates. The 
final  oxygen  tensions  in  the  chambers  were  5%  and  10%,  respectively.  Controls  included  parallel 
cultures in which cells were exposed to normoxia (21% oxygen tension). 12 h later, the supernatants 
were collected and put in another 96-well cell culture plates. The ROS in the supernatants was measured 
by  ROS  assay  kit  (Genmed,  China).  Briefly,  the  samples  were  incubated  with  10  μL  3,3',5,5' 
tetramethylbenzidine (TMB Substrate) at 37 ° C for 1 h. This would result in blue color development 
proportional  to  the  amount  of  ROS  and  the  level  of  ROS  in  each  sample  was  measured  with  the 
spectrophotometer at a wavelength of 650 nm. 
2.6. Treatment of BRL-3A Cells with Reduced Glutathione  
BRL-3A cells were cultured in 6-well plates. At 80% confluency, the medium was changed to 
serum-free DMEM medium containing reduced glutathione (0, 0.5, 2.5, 10 mmol/L). After 30 min, the 
plates  were  incubated  in  a  chamber  flushed  with  air  mixture  containing  1%  O2,  5%  CO2  and  
94% N2 for 30 min. The chambers were sealed and placed at 37 ° C and incubated for 12 h. The level of 
ROS in each sample was measured according to the method above. Meanwhile, the supernatants of 
BRL-3A  were  collected  from  the  cells  and  passed  through  a  0.22  μm  filter.  The  filtrate  was  
designated as ROS-reduced-hepatocyte-conditioned medium and stored at −20 ° C for later use. The  Int. J. Mol. Sci. 2011, 12                       
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ROS-reduced-hepatocyte-conditioned  medium  was  used  to  culture  HSC-T6  cell  as  previously 
described for 6 h, 12 h, and 24 h. Then the supernatants were collected, and total protein and RNA 
were extracted from HSC-T6 cells. 
2.7. Statistical Analysis 
Experiments  were  repeated  at  least  three  times.  The  results  were  presented  as  means  ±   SEM. 
Comparison of multiple parameters was performed with one-way ANOVA test (SPSS 11.5), followed 
by Tukey-Kramer’s post hoc test. p < 0.05 was considered as statistically significant. 
3. Results 
3.1. Hepatocyte Conditioned Medium Upregulates MMP-2 Expression in HSCs 
Our  prior  study  has  shown  that  hypoxia  could  regulate  the  expression  of  MMP-2  mRNA  in  
HSC-T6  cell  [16,17,21].  To  investigate  whether  hypoxic  hepatocytes  affect  the  expression  of  
MMP-2 mRNA in HSC-T6 cells, we measured MMP-2 mRNA level in rat HSC-T6 cells cultured in 
hepatocyte-conditioned medium for 6, 12 and 24 h, respectively. As shown in Figure 1, real-time 
RT-PCR analysis showed that MMP-2 mRNA expression was increased in HSC-T6 cells treated 
with  hepatocyte-conditioned  medium.  Time  factor  analysis  by  one-way  ANOVA  showed  that  
MMP-2 mRNA level in HSC-T6 cells treated with the conditioned medium was significantly higher 
than that in the controls (p < 0.001). These results indicate that hepatocyte conditioned medium 
upregulates  MMP-2  expression  in  HSCs.  To  provide  further  evidence  for  this,  we  performed 
Western blot analysis to examine MMP2 expression at the protein level in HSC-T6 cells cultured 
with  hepatocyte-conditioned  medium  at  6,  12  and  24  h,  respectively.  The  results  showed  that  
MMP-2 protein was induced in HSC-T6 cells treated with the hepatocyte-conditioned medium. The 
protein level of MMP-2 at 12 h was higher than that at 6 h and 24 h (Figure 2). Taken together,  
these  data  suggest  that  MMP-2  expression  in  HSC-T6  cells  exhibited  a  slow  response  to  
hepatocyte-conditioned medium.  
To find out whether anoxic hepatocytes affect the  activity of MMP-2 in HSC-T6 cells, gelatin 
zymography  was  conducted.  The  results  showed  that  MMP-2  activity  was  inhibited  by  
hepatocyte-conditioned medium. The effect within 24 h was more intensive. Time factor analysis by 
one-way ANOVA test showed that MMP-2 activity in HSC-T6 cells in hepatocyte-conditioned medium 
and in the controls had significant differences (p = 0.024). Group factor analysis (p < 0.001) was 
shown in Figure 3, indicating that hepatocyte-conditioned medium inhibits MMP-2 activity in rat HSCs.  
3.2. Reduced Glutathione Antagonizes the Generation of ROS in the Supernatants of Hepatocytes 
Because  ROS  could  regulate  MMP-2  expression,  we  determined  the  level  of  ROS  in  the 
supernatant of hepatocytes treated with hypoxia. BRL-3A cells were treated with different levels of 
oxygen (5% O2, 10% O2, and 21% O2) for 12 h and supernatants were collected for quantitative 
colorimetric assay. The results showed that ROS level gradually increased with the decrease of oxygen 
tension (Figure 4A). To investigate whether reduced glutathione (GSH) could eliminate the release of 
ROS to the supernatant of hepatocytes treated with hypoxia, we treated BRL-3A cells with GSH  Int. J. Mol. Sci. 2011, 12                       
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(0, 0.5, 2.5, 10 mmol/L), and examined ROS level in the conditioned medium. The results showed that 
the level of ROS in hypoxia conditioned medium decreased gradually with the increase of reduced 
glutathione (Figure 4B).  
Figure  1.  Hepatocyte  conditioned  medium  upregulates  MMP-2  mRNA  expression  in 
HSCs. Relative MMP-2 mRNA level was determined by Real-time RT-PCR in HSC-T6 
cells  treated  with  hepatocyte  conditioned  medium,  serum-free  DMEM  medium  and 
hepatocyte-conditioned  control  medium  (normoxia  conditioned  medium)  for  6,  12  and  
24 h. Data were expressed as means ±  SEM from 3 independent experiemnts. * p < 0.05, 
** p < 0.01, *** p < 0.001, and Δp > 0.05.  
 
Figure 2. Hepatocyte conditioned medium upregulates MMP-2 protein expression in HSCs. 
Western blot analysis showing MMP-2 protein level in HSC-T6 cells cultured in hepatocyte 
conditioned  medium,  serum-free  DMEM  medium  and  hepatocyte-conditioned  control 
medium (normoxia conditioned medium) for 6, 12 and 24 h. The specificity of MMP-2 
antibody was demonstrated by the detection of MMP2 as a 72 KD protein. Shown were 
representative  blots  from  three  independent  experiments  with  similar  results.  Data  were 
expressed as means ±  SEM from 3 independent experiments. * p < 0.05, and Δp > 0.05.  
 Int. J. Mol. Sci. 2011, 12                       
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Figure 3. MMP-2 activity measured by gelatin zymography in HSC-T6 cells cultured with 
hepatocyte  conditioned  medium  (hepatocyte  conditioned  culture),  serum-free  DMEM 
medium, and hepatocyte-conditioned control medium at 6, 12 and 24 h. Typical results 
were  shown  from  independent  experiments  performed  at  least  three  times.  Data  were 
expressed as means ±  SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 and Δp > 0.05. 
 
Figure  4. GSH antagonizes the generation of ROS in the supernatants of hepatocytes.  
(A) BRL-3A cells were treated with different levels of oxygen (5% O2, 10% O2 and 21% 
O2) for 12 h. ROS in the supernatants was quantified using a colorimetric assay. Data were 
expressed as means ±  SEM from 3 independent experiments. * p < 0.05, ** p < 0.01 vs. 
Control;  (B)  BRL-3A  cells  were  treated  with  GSH  (0,  0.5,  2.5,  10  mmol/L)  and  then 
exposed to 5% oxygen for 12 h. The ROS level in the hypoxia conditioned medium was 
analyzed.  Data  were  expressed  as  means  ±   SEM  from  3  independent  experiments.  
* p < 0.05, *** p < 0.001 vs. group treated with 0 mmol/L GSH. 
   
3.3. ROS Generated by Hypoxic Hepatocyte Contributes to the Downregulation of MMP-2 Expression 
and Activity in HSCs 
To confirm that ROS generated by hypoxic hepatocyte is one of the main factors that contribute to 
increased expression of MMP-2 in HSCs, we examined MMP-2 expression at both mRNA and protein 
levels  in  HSC-T6  cells  cultured  in  ROS-neutralized-hepatocyte  conditioned  medium.  Real-time  Int. J. Mol. Sci. 2011, 12                       
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RT-PCR analysis showed that with the increase of GSH concentration, MMP-2 mRNA expression in 
HSC-T6 cells was significantly inhibited (Figure 5A, p < 0.001). In addition, Western blot analysis 
showed that MMP-2 protein expression in HSC-T6 cells was reduced corresponding to increased GSH 
concentration (Figure 5B, p < 0.001). The result of gelatin zymography (Figure 5C) was consistent 
with Real-time RT-PCR and Western blot (p < 0.001).  
Figure  5.  ROS-neutralized  hepatocyte  conditioned  medium  downregulates  MMP-2 
expression  and  activity  in  HSCs.  BRL-3A  cells  were  treated  with  reduced  glutathione  
(0, 0.5, 2.5, 10 mmol/L) and exposed to 5% oxygen for 12 h. Then the supernatant was 
collected and HSC-T6 cells were cultured with ROS-neutralized-hepatocyte-conditioned 
medium  for  6,  12  and  24  h.  As  a  control,  HSC-T6  cells  were  cultured  in  serum-free 
DMEM medium. (A) relative MMP-2 mRNA level in HSC-T6 cells were determined by 
Real-time  RT-PCR.  Data  were  expressed  as  means  ±   SEM  from  3  independent 
experiments. * p < 0.05 vs. the former group; (B) MMP-2 protein level in HSC-T6 cells 
was detected by Western blot. Shown were representative blots from three independent 




3.4. Hepatocyte Conditioned Medium Upregulates MMP-2 Expression in HSCs via NF-κB Signaling 
To investigate whether ROS in hepatocyte conditioned medium modulates MMP2 expression via 
NF-κB signaling, we measured the level of phospho-IκB-α protein in HSC-T6 cells cultured with 
serum-free DMEM, normoxia conditioned medium, hypoxia conditioned medium, respectively, for  
12 h. Western blot analysis showed that phospho-IκB-α protein level in HSC-T6 cells treated with the 
hypoxia conditioned medium was increased compared to that in cells cultured in normoxia conditioned Int. J. Mol. Sci. 2011, 12                       
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medium (Figure 6A, p < 0.05). BAY 11-7082 is a commonly used NF-κB inhibitor. When we treated 
HSC-T6 cells with BAY 11-7082, we found that MMP2 expression in HSC-T6 cells was significantly 
inhibited compared to cells treated with vehicle control (Figure 6B, p < 0.05). As expected, BAY  
11-7082  inhibited  the  activation  of  NF-κB  in  HSC-T6  cells  (Figure  6C).  Collectively,  these  data 
suggest that NF-κB signaling mediates ROS-induced MMP-2 expression in HSCs. 
Figure  6.  NF-κB  signaling  mediates  ROS-induced  MMP-2  expression  in  HSCs.  
(A) Western blot analysis showing MMP-2 and phosphor-IκB-α levels in HSC-T6 cells 
cultured  in  hepatocyte  conditioned  medium,  serum-free  DMEM  medium  and  
hepatocyte-conditioned  control  medium  (normoxia  conditioned  medium).  Data  were 
expressed  as  means  ±   SEM  from  3  independent  experiments.  *  p  <  0.05,  Δp  >  0.05;  
(B) HSC-T6 cells were treated by BAY 11-7082 (100 μM) or vehicle control and MMP-2 
protein level was detected by Western blot. Data were expressed as means ±  SEM from 3 
independent experiments. * p < 0.05 vs. vehicle control; (C) HSC-T6 cells were treated by 
BAY 11-7082 (100 μM) or vehicle control, total and phosphor IκB-α levels were detected 
by Western blot. Data were expressed as means ±  SEM from 3 independent experiments. 
*** p < 0.01 vs. vehicle control. 
   




Hypoxia is crucially involved in acute and chronic liver injury. As a repair process in response to a 
variety  of  chronic  injury  stimuli,  the  progression  of  liver  fibrosis  is  accompanied  by  hypoxia. 
Following a fibrogenic stimulus, HSCs are activated which then synthesize and deposit a large amount 
of ECM in the liver [22–24]. The activation of HSCs is a key event of fibrogenesis [4,7]. We have 
found that hypoxia induced the expression of MMP-2 at both mRNA and protein levels, but inhibited 
its  activity  in  the  in  vitro  assay  [16–18].  In  vivo  experiment  suggested  that  at  the  beginning  of  
liver  fibrosis,  MMP-2  expression  and  activity  were  decreased,  and  fewer  HSCs  were  activated.  
However,  during  the  development  of  fibrosis,  MMP-2  activity  was  increased,  which  degrades  
collagen  Ⅳ  [17,25–27]. Given  these  inconsistent  results  between in  vivo and in vitro studies, we 
believe that cell–cell interaction is involved in the regulation of MMP-2 expression and activity at low 
oxygen  level  in  vivo.  Therefore,  in  this  report  we  investigated  the  mechanism  by  which  hypoxic 
hepatocytes regulates MMP-2 expression in HSCs.  
First,  we  examined  whether  hypoxic  hepatocytes  affect  MMP-2  expression  in  HSC-T6  cells.  
Real-time RT-PCR analysis showed that hypoxic hepatocytes may secrete some factor(s) to affect 
MMP-2 expression at mRNA level in HSC-T6 cells. Consistent with RT-PCR analysis, Western blot 
analysis further showed that hepatocyte-conditioned medium induced the expression of MMP-2 in 
HSC-6T cells at protein level. Taken together, these data indicate that hypoxic hepatocytes release 
some factor(s) to upregulate the expression of MMP-2 in HSC-T6 cells.  
Next,  a  serial  of  experiments  was  conducted  to  identify  the  factor(s)  released  from  hypoxic 
hepatocytes responsible for the upregulation of MMP-2 expression in HSCs. It is known that ROS 
serves as a signal molecule that regulates many important cellular events, such as transcription factor 
activation,  gene  expression,  cell  differentiation  and  proliferation.  ROS  is  also  involved  in  the 
regulation of MMP-2 expression and activation, mainly through Ras and mitogen activated protein 
kinase (MAPK) signaling cascades [21,28]. Therefore, we detected ROS level in the supernatant of  
BRL-3A cells treated with different levels of oxygen and found that with the decrease of oxygen 
tension, ROS was gradually increased. Reduced glutathione (GSH) is a non-protein antioxidant and 
can protect cells from ROS damage. After treatment with GSH, we detected ROS in the supernatants 
of hypoxia conditioned medium to determine whether ROS can be scavenged by reduced glutathione. 
The results evidently demonstrated that as the concentration of GSH increased, the level of ROS in the 
supernatants of hypoxia conditioned medium was gradually decreased, proving that ROS generated in 
hepatocytes was scavenged efficiently by reduced glutathione.  
To provide further evidence that ROS generated in hepatocytes contributes to the upregulation of 
MMP-2  expression  in  HSC-T6.  Last,  we  characterized  the  potential  mechanism  by  which  ROS 
regulates MMP-2 expression in HSCs. By probing phospho-IκB-α protein level as an indication of the 
activation  of  NF-κB  signaling,  we  found  that  hypoxia  conditioned  medium  induced  increased 
phospho-IκB-α  protein  level  in  HSC-T6  cells,  corresponding  to  increased  MMP-2  protein  level. 
Furthermore, inhibition of NF-κB signaling by specific inhibitor BAY 11-7082 led to reduced MMP2 
protein level in HSC-T6 cells. Based on these data we speculate that NF-κB signaling is an important, 
although not exclusive, signaling pathway that mediates ROS-induced MMP-2 expression in HSCs. Int. J. Mol. Sci. 2011, 12                       
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Gelatin  zymography  analysis  (Figure  5C)  showed  that  hypoxic  hepatocytes  released  ROS  to 
persistently inhibit the activity of MMP-2 in HSC-T6 cell within 24 h. This resutl was consistent with 
that of Real-time RT-PCR and Western blot. However, in contrast to the result showed in Figure 3, we 
found that MMP-2 activity was inhibited by hepatocyte-conditioned medium. These results suggest 
that ROS may be the main factor released by anoxic hepatocyte to regulate MMP-2 mRNA and protein 
expression, but may not be the main factor that regulates MMP-2 activity.  
MMP-2 is secreted as a latent form of zymogen and can be activated when the pro-domain is 
cleaved  and  bound  to  TIMP-2  and  MT1-MMP.  Many  factors  are  involved  in  regulating  MMP-2 
activity. As the main inhibitor, tissue inhibitor of metalloproteinase (TIMP) is the most important 
regulator  of  MMP-2  activity.  It  is  possible  that  the  factor  released  by  anoxic  hepatocyte  
regulates MMP-2 activity by means of disturbing the balance between MMP-2 and its endogenous  
inhibitors TIMPs [29]. As a novel membrane-anchored matrix metalloproteinase (MMP) inhibitor,  
reversion-inducing cysteine-rich protein with Kazal motifs (RECK) also plays a role in the regulation 
of MMP activity. RECK inhibits MMP-2, MMP-9, and membrane type-1 MMP (MMP-14) secretion 
and  activity  [30].  MMP-2  is  Zn-dependent  enzyme.  Therefore,  Zn
2+  is  necessary  for  MMP-2  
activity [31]. In addition, MMP-2 is also directly activated by oxidizing the sulphydril bond between a 
cysteine residue of the prodomain and the Zn
2+ catalytic center, resulting in partial enzyme activation 
followed by an intramolecular cleavage of the propeptide [32]. In our future study we will identify the 
factors generated by anoxic hepatocytes that inhibit MMP2 activity.  
MMP-2  has  been  shown  to  promote the  formation  and  development of  liver fibrosis, 
mainly through  the regulation  of  the  activation,  proliferation,  and  migration  of  HSCs. In  vitro 
studies found that MMP-2 could degrade type IV collagen-rich matrix around the HSCs, which could 
activate HSCs. The activated HSCs proliferate actively, produce large amounts of extracellular matrix, 
and are  main  source  of MMP-2  in  the  liver  [33].  In  addition,  oxidative  stress  induced  by  some 
pathogenic factors promoted the proliferation and migration of HSCs through MMP-2 [34]. MMP-2 
also promoted the proliferation of HSCs through release of growth factors stored in the matrix [35]. 
Furthermore,  MMP-2  has  been  shown  to  induce  the  release  of  VEGF  [36],  which  is  involved 
in hepatic sinusoidal capillarization and promotes the development of liver fibrosis [7,37–39]. Further 
study is important to investigate the mechanism underling the regulation of the expression and activity 
of MMP-2 in liver fibrosis. 
5. Conclusions  
In summary, in this study we provide several lines of evidence that ROS is an important factor 
released  by  hypoxic  hepatocyte  to  regulate  MMP-2  expression  in  HSCs,  and  NF-κB  signaling  is 
crucially involved in ROS-induced MMP-2 expression in HSCs. Our findings suggest that strategies 
aimed at antagonizing the generation of ROS in hypoxic hepatocytes and inhibiting NF-κB signaling 
in HSCs may represent novel therapeutic options for liver fibrosis. Int. J. Mol. Sci. 2011, 12                       
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Figure 7. Hypoxic hepatocytes regulate MMP-2 expression and activity in Hepatic Stellate Cells. 
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